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indicating high levels of random measurement error. Three of the SF-36 domains
did not distinguish between WHO functional classes. Only two of the SF-36 do-
mains (role physical and general health perceptions) met the full psychometric
criteria of the study. In contrast, all CAMPHOR scales exhibited good test retest
reliability and distinguished significantly between WHO functional classes.
CONCLUSIONS:The CAMPHOR has superior psychometric properties, compared to
the SF-36, in the assessment of QoL in individuals with PH.
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OBJECTIVES: To assess the use of quality of life questionnaires in polish cardiac
patients, as well as research methods used by polish authors in terms of interna-
tional quality of life research guidelines. METHODS: Systematic literature review
was performed in order to collect publications assessing quality of life in cardiac
patients in Poland. Medical databases and the most important health agencies
websites were searched for HRQoL assessment guidelines. Inclusion criteria: stud-
ies carried in the Republic of Poland; studies in which authors were using HRQoL
questionnaires in cardiac patients. Exclusion criteria: Studies carried outside of
Poland; studies estimating HRQoL among patients with vascular diseases; case
reports; researches and review papers without HRQoL assessment. Based on the
international guidelines, “checklist” consisting of 19 statements and questions was
created as a basis for data extraction from accessed publications. RESULTS: As a
result of systematic literature review and inclusion criteria application, 131 polish
publications were included in this analysis. 26% of all researches were based on
questionnaires designed by the authors for their own needs, of which 71% have
never been validated. Results of questionnaires were calculated using official key
only in 43% of publications. Among the included studies, 63% assessed HRQoL as a
primary endpoint. Observational studies assessing HRQoL in polish cardiac pa-
tients without any interventions were the most common (41%). At the same time,
36% of studies were related to surgical intervention. CONCLUSIONS: Polish studies
assessing HRQoL in cardiac patients often do not meet all the requirements stated
in international guidelines. Promoting of the results of this work can increase the
awareness of polish authors in terms of proper HRQoL measures.
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OBJECTIVES: To assess the health-related quality of life (HrQoL) in patients with
atrial fibrillation (AF) in Germany and to identify the influence of the associated
AF-specific symptoms on HrQoL. METHODS: HrQoL of AF patients recruited into a
prospective cohort study was assessed by using the written version of the SF 36.
General HrQoL as well as physical and mental component summary scores were
calculated for each patient. Secondly, AF-related symptoms based on the EHRA AF
symptoms classification (palpitations, fatigue, dizziness, dyspnea, chest pain, anx-
iety) were collected by asking each patient to fill out written questionnaires during
visiting a GP. To identify the influence of these symptoms on HrQoL, a linear re-
gression was conducted for each component summary score, while controlling for
additional socio-demographic/AF-related clinical parameters. RESULTS: A total of
526 AF-patients were recruited in 71 study centers (female patients: 45.1 %, average
age: 73.2 years, average CHA2DS2-VASc score: 3.8). The average SF-36-physical
summary score was 38.6 (SD: 10.4). The average SF-36 mental component score was
46.5 (SD: 11.8). Only 14.8 % of the patients reported none of the EHRA-symptoms.
The most frequent symptom was fatigue (72.1 % of all patients). The results of the
first multivariate regression (R20.349) showed that the most important factors
explaining the SF-36-physical component score were fatigue, chest pain, dizziness
and dyspnea. Only two of the control variables had a significant influence on phys-
ical HrQoL (age; number of medications taken). In the second estimate addressing
mental HrQoL (R20.349), none of these factors was significant. The most impor-
tant factors explaining mental HrQoL were palpitations, dizziness and anxiety.
CONCLUSIONS: AF patients in real life care have a limited physical/mental HrQoL.
AF-related symptoms significantly explain the level of HrQoL. Consequently, in
order to increase/maintain the HrQoL of AF patients, it is important to control/
improve scores measured for AF-related symptoms.
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OBJECTIVES: Bleeding is a common experience for acute coronary syndrome (ACS)
patients who receive anti-platelet medications. “Nuisance” bleeding and bruising –
non-life threatening events that occur in the patients’ everyday lives and may
impact medication adherence – is not often assessed in clinical trials and existing
measures may not capture all relevant aspects. In this study, we used qualitative
interviews to better understand how patients experience nuisance bleeding and
bruising and its impact. METHODS: One-hour interviews were conducted using a
semi-structured interview guide with patients who had experienced ACS in the
past year. All participants were taking clopidogrel at the time of enrollment into the
study and reported experiencing nuisance bleeding and bruising. Most patients
were male (70%) and white (80%) and the average age was 63.5 years old. Interview
responses were coded using ATLAS.ti software. Data were analyzed by extracting
relevant themes emerging from the interviews and by calculating the percent of
patients expressing a specific concept related to nuisance bleeding and bruising.
RESULTS: Prominent features included the amount of bleeding, difficulty stopping
the bleeding, and the size and color of bruises. Frequency was an important issue
for patients; approximately one-third of patients reported experiencing nuisance
bleeding daily. Patients most often reported that bleeding events lasted only min-
utes, but that bruises often did not heal for weeks. Nuisance bleeding and bruising
appeared to have a significant negative impact on the patients’ daily lives, as it
resulted in behavior changes to avoid bleeding and bruising events and a variety of
negative emotions (e.g., embarrassment, frustration, fear). CONCLUSIONS: Nui-
sance bleeding and bruising can have a significant impact on the lives of ACS
patients on anti-platelet medications. The data from this qualitative interview
study may allow for improved measures of nuisance bleeding and bruising that can
be administered in studies examining antithrombotic therapies.
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OBJECTIVES: Patients with cardiovascular disease (CVD) experience a number of
symptoms, such as tiredness, that can limit their physical activities and disrupt
daily life. Increased inflammation may independently contribute to the experience
of these symptoms and functional limitations, in addition to increasing the risk of
CVD and acute events. The goal of this study was to perform a qualitative review of
published studies that address the link between inflammation and patient func-
tioning among patients with cardiovascular disease. METHODS: Articles were
identified through MEDLINE and PubMed. Search terms included “inflammation,
inflammatory markers, CRP, TNF-, and interleukins” crossed with “fatigue, de-
pression, physical activity, sleep, function, and cardiovascular.” The search re-
turned 938 articles, a total of 112 abstracts were reviewed, and 46 full articles were
examined. Of these, 8 addressed patients with chronic or acute cardiovascular
disease and were included in the review. RESULTS: The articles examined multiple
inflammatory markers, including IL-1, IL-6, TNF-, CRP, IL-10, IL-8, neopterin,
sICAM-1, and IL-1ra. Symptoms and functional limitations measured included fa-
tigue/tiredness, irritability, depression, demoralization, and physical activity/exer-
cise. Significant associations were observed in all 8 studies. The relationship be-
tween inflammation, IL-6 in particular, and tiredness was consistently seen.
Evidence also supported a relationship with depressed mood, but the association
was not uniform across inflammatory markers. Inflammation was also associated
with physical activity, with one study showing that exercise reduced hsCRP and
inflammatory cytokines. CONCLUSIONS: Symptoms and limitations on physical
functioning can substantially burden patients with CVD. Although additional re-
search is needed, this review suggests that inflammatory processes may indepen-
dently contribute to this patient burden. Reducing inflammation may not only
reduce the risk of CVD and associated events, but also directly improve symptoms
and improve functioning. It will be useful to include outcomes assessing these
concepts in trials examining anti-inflammatory treatments in CVD patients.
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OBJECTIVES: To assess the prevalence and impact of dyspepsia among Japanese
Atrial Fibrillation (AF) patients.METHODS: The 2008, 2009, and 2010 Japan National
Health and Wellness Survey (NHWS) datasets were used in this study. The NHWS
is an Internet-based survey administered to the adult population in Japan using a
random stratified sampling framework to ensure demographic representativeness.
Among patients who reported a diagnosis of AF (N565), those with comorbid
dyspepsia were compared with those without dyspepsia on demographics and
health history. These groups were also compared on health status (using the SF-
12v2), work productivity (using the WPAI), and health care resource use (physician
visits, emergency room [ER] visits, and hospitalizations) in the past six months
using multivariate regression modeling and controlling for baseline differences.
RESULTS: Dyspepsia was the most common non cardiovascular comorbidity, af-
fecting over a third (37.4%) of AF patients. This prevalence was higher than in
general population (21.3%). Its presence was not associated with any demographic
or general health history variables. However, patients with dyspepsia used more
AF medications (2.05 vs. 1.54) and had been diagnosed more recently (9.97 vs. 10.58
years). Adjusting for these differences, patients with dyspepsia reported signifi-
cantly worse physical health status (PCS scores: 41.32 vs. 45.66) and health utilities
(0.70 vs. 0.76) (all p0.05). Those patients also reported significantly more overall
work impairment (29.65% vs. 17.02%) and more physician visits (19.35 vs. 12.62),
and ER visits (0.40 vs. 0.14) in the past six months (all p.05). CONCLUSIONS:
Dyspepsia is common among Japanese AF patients. Even after adjusting for con-
founding variables, dyspepsia was significantly associated with poorer health sta-
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tus, greater work-related impairments, and increased health care resource use.
Given the additional burden of this comorbidity, the management of dyspepsia
among patients with AF should be a greater area of focus.
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OBJECTIVES: To analyse the association between Health Related Quality of Life
(HRQoL) and age, in hypertensive patients and the correlation between HRQoL
reported by patients and evaluated by their doctors. METHODS: Observational,
cross-sectional, multi-centre study, in Primary and Specialised Care. Inclusion of
5,031 hypertensive patients, selected by quotes according to three age groups (65,
65-79,  80 years) was planned. Selection criteria were: patients whose age was
over 18, diagnosed as having hypertension at least one year before inclusion and
attended a follow-up visit. Information related to hypertension, basic socio-demo-
graphic and clinical data, the self-administered specific questionnaire MINICHAL
for the evaluation of HRQoL (higher scores indicative of lower HRQoL), and a visual
analogue scale (VAS) for the general evaluation of HRQoL (higher scores indicative
of higher HRQoL) by patients and doctors, were recorded. Data of 4,346 eligible
patients were included. HRQoL-age correlation was analysed by Spearman’s-rho,
differences among age groups by Kruskal-Wallis and patient/doctor agreement by
the intraclass correlation coefficient (ICC). RESULTS: Mean age (SD) was
68.35(12.60). 38.1% of patients were under 65, 36.9% between 65 and 80 and 25.0%
were over 80 years old. 54.5% were men. Mean time since diagnosis was 10.33(7.68)
years. 34.2% had a family history of high blood pressure. Mean scores in MINICHAL
were: State of Mind dimension 8.07(5.83), Somatic Manifestations dimension
3.24(3.06). Worsening of both dimensions was found when comparing groups of
higher age (p0.001) as well as significant moderate correlations of both dimen-
sions with age (0.335, p0.001; 0.397 p0.001). Mean(SD) VAS score for doctors’
evaluation was 66.84(15.82) and 63.93(18.46) that of patients; ICC for agreement was
0.697 (0.672, 0.687 and 0.663 by age groups). CONCLUSIONS: An impact of age on
HRQoL worsening is evidenced. Patient/doctor agreement in the evaluation of
HRQoL is adequate; however doctors trend to overestimate the HRQoL of patients.
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OBJECTIVES: To determine the health related quality of life (HRQOL) of patients
with heart failure (HF) hospitalized in the Canary Islands and to estimate their
utilities by analyzing the influence of sociodemographic and clinical factors such
as gender or severity according to New York Heart Association (NYHA) classifica-
tion. A secondary objective is to obtain utilities to be used in an economic model to
evaluate a cardiac device. METHODS: Descriptive analysis within a prospective
observational multicenter study of a cohort of patients with HF admitted to cardi-
ology or internal medicine units at several hospitals in the Canary Islands, Spain.
HRQOL was assessed using the EQ-5D questionnaire among others. Utility was
estimated for the entire sample and for subgroups of patients, using the Spanish
tariffs VAS (visual analog scale) and TTO (time trade-off). RESULTS:We present the
results of a sample of 176 patients enrolled so far (51% male, mean age 74 years).
Average utility (SD) of the entire sample is 0.5297 (0.2107) (VAS rate). Women re-
ported poorer HRQOL than men (0.5182 vs. 0.5421); HRQOL is lower in health states
of lower functional capacity: 0.6400 in patients with NYHA-I and 0.4491 in patients
with NYHA-III. CONCLUSIONS: Differences between sub-groups and overall low
HRQOL were observed, possibly due to the hospitalization of surveyed patients.
These local findings coincide with the international literature and may be useful
for developing the economic model.
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OBJECTIVES: To compare work productivity impairment between Russian patients
with those in the 5EU and US and assess whether conditions have similar impact
across these geographies.METHODS:The study included data from the 2011 Russia
(N10,039), US (N75,000), and 5EU (N 57,512) National Health and Wellness
Survey, a survey representative of urban adults in Russia and total adult popula-
tions of the US and each 5EU country. Respondents self-reported physician diag-
nosis of type 2 diabetes (T2D) and cardiovascular (CV) conditions, as well as their
height and weight used to calculate obesity (BMI30). Work productivity impair-
ment and impairment in non-work activities was assessed with the Work Produc-
tivity and Activity Impairment (WPAI) questionnaire. Two-way ANOVAs tested for
differences in work productivity impairment by geography and condition.
RESULTS: There were regional differences in mean health-related work impair-
ment, with Russia the highest (22.6%), followed by 5EU (19.4%) and US (14.9%;
p0.001). Collapsing across geographies, obesity, T2D, and CV conditions were
each associated with more impaired work productivity (all ps0.01), but the mag-
nitude of the decrement associated with each disease depended on region (all
ps0.01). The incremental work productivity loss associated with obesity was
smallest in Russia (1.5%), compared with 5EU (3.9%) and US (2.7%). T2D patients in
Russia and 5EU experienced similar incremental work productivity impairment
(8.5%), while US T2D patients showed a difference of 5.0%. Similarly, Russians with
CV conditions were more impaired than in 5EU and US when compared with
non-CV patients (8.1% vs. 7.1% and 4.4%, respectively). CONCLUSIONS: Russians
have greater health-related work impairment than adults in US and 5EU. The in-
cremental burden of obesity, T2D, and CV conditions in Russia appears to differ
from the US and 5EU, being relatively small for obesity but greater for T2D and CV
conditions. These differences highlight the importance of country-specific infor-
mation for these markets.
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Anticoagulants are recommended for stroke prevention in atrial fibrillation (AF),
unfortunatly they also increase the risk of bleeding. For this reason, physicians face
benefit-risk trade-offs when prescribing anticoagulants to AF patients. Although
the unmet medical need for safer anticoagulants has been documented, the actual
patients and physicians preferences for outcomes associated with anticoagulants
are yet to be documented. OBJECTIVES: To quantify Japanese patients and physi-
cians preferences for benefits and risks associated with the use of anticoagulants in
AF and to enable cross-patient and physician comparison.METHODS: Patients45
years old with a self-reported physician diagnosis of AF, and board-certified inter-
nists, cardiologists, neurologists and neurosurgeons currently treating AF patients
were invited to complete a web-enabled, choice-format conjoint survey that in-
cluded a series of trade-off questions. Each trade-off question included a pair of
hypothetical anticoagulants defined by therapy-induced changes in the risk of
stroke, myocardial infarction, embolism, and bleeding. In addition, respondents
were asked to revisit their anticoagulant choice based on the risk of all-cause death
and on the monitoring requirement. Patients were asked to choose anticoagulants
for themselves, while physicians chose anticoagulants for virtual patients. Ran-
dom-parameters logit was used to estimate a relative preference weight for the risk
of each event based on respondents’ choices in the trade-off questions. RESULTS:
A total of 152 patients and 164 physicians completed the survey. Overall patients
and physicians considered all-cause death to be the least desirable outcome.
Among non-fatal outcomes, patients considered the risk of disabling stroke to be
2.6 times more important than extra-cranial major bleeding and 16 times more
important than non-major clinically relevant bleeding compared to 1 time and 2.7
times for physicians. CONCLUSIONS: Japanese patients and physicians have dif-
ferent preferences for non-fatal outcomes associated with anticoagulants, with
patients willing to tolerate a greater risk of bleeding for stroke prevention than
physicians.
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Although effective for stroke prevention in atrial fibrillation (AF), anticoagulants
increase the risk of bleeding. The relative importance of benefits and risks associ-
ated with anticoagulants is influenced by various factors and has mostly been
documented only in physicians. OBJECTIVES: To identify patients characteristics
influencing the relative importance of non-fatal outcomes associated with
anticoagulants. METHODS: Data from a choice-format conjoint survey asking AF
patients to choose between hypothetical anticoagulants were used to estimate
importance weights for non-fatal outcomes associated with anticoagulants. The
influence of patients characteristics was tested by evaluating the significance of
interactions between importance weights and age, gender, prior use of anticoagu-
lants, personal history of stroke, family history of stroke and personal or family
history of bleeding. RESULTS: A total of 152 patients completed the survey. Only
two patients characteristics significantly influenced the relative importance of
non-fatal outcomes associated with anticoagulants. Overall, the least desirable
non-fatal outcome was disabling stroke. Using disabling stroke as a reference,
patients characteristics such as prior use of anticoagulants increased the relative
importance of non-disabling stroke by 48%, major extra-cranial bleeding by 12%
and non-major clinically relevant bleeding by 82%. On the other hand, personal or
family history of bleeding increased the relative importance of major extra-cranial
bleeding by 19% and non-major clinically relevant bleeding by 34% while decreas-
ing the relative importance of non-disabling stroke by 15%. CONCLUSIONS: This
study documents the impact of patients prior experience on relative importance of
non-fatal outcomes associated with anticoagulants. Proper explanation of the ben-
efits and risks of anticoagulants may play a role in patients understanding and
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